PREP Act

Bill 118 s 3380, also known as the PREP Act, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to enhance the Public Readiness and Emergency Preparedness Act (PREP Act) in order to better prepare the country for public health emergencies.

The PREP Act was originally passed in 2005 and provides liability protections for certain individuals and entities involved in the development, manufacture, distribution, administration, and use of medical countermeasures during public health emergencies. These protections are crucial in encouraging the rapid development and distribution of vaccines, treatments, and other medical supplies during times of crisis.

The proposed enhancements in Bill 118 s 3380 include expanding the definition of covered countermeasures to include products used to diagnose, mitigate, prevent, or treat diseases or conditions caused by emerging infectious diseases, such as COVID-19. This expansion would ensure that a wider range of medical products are eligible for liability protections under the PREP Act. Additionally, the bill seeks to clarify and strengthen the liability protections for individuals and entities involved in the distribution and administration of covered countermeasures. This would help to ensure that healthcare providers, manufacturers, and other stakeholders are protected from legal action while responding to public health emergencies. Overall, Bill 118 s 3380 aims to improve the country's ability to respond to public health emergencies by enhancing the PREP Act and providing greater liability protections for those involved in the development and distribution of medical countermeasures.